Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

FES (16α-[18F]-Fluoro-17β-estradiol)-PET: Towards a New Standard to Stage Locally Advanced and Recurrent, Estrogen Receptor Positive (ER+) Breast Cancer? Pilot Study to Compare [18F]FES-PET and [18F]FDG-PET (FORESIGHT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03726931
Recruitment Status : Active, not recruiting
First Posted : November 1, 2018
Last Update Posted : October 8, 2021
Sponsor:
Information provided by (Responsible Party):
C. Menke- van der Houven van Oordt, VU University Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : January 29, 2023
Estimated Study Completion Date : January 29, 2023